Mirum Pharmaceuticals MIRM
NASDAQ MIRM
$82.93 -0.99 (-1.18%)
At close: Oct 2, 2026 · 4:00 PM EDT

Mirum Pharmaceuticals (MIRM) Return on Capital Employed [ROCE] (2019 - 2026)

Updated

Mirum Pharmaceuticals (MIRM) posted Return on Capital Employed [ROCE] of -111.92% for Q2 2026, down 101.78 percentage points from -10.13% a year earlier but up 22.15 percentage points from the prior quarter.

Analysis

Mirum Pharmaceuticals (MIRM) Return on Capital Employed [ROCE] (2019 - 2026) Analysis & Trends

For FY2025, Mirum Pharmaceuticals' Return on Capital Employed [ROCE] came in at -4.02%, up 12.45 percentage points from FY2024.

  • Annual Return on Capital Employed [ROCE] has increased for four consecutive years, with a five-year change of +55.47 percentage points (FY2020 to FY2025).
  • In prior years, Mirum Pharmaceuticals' Return on Capital Employed [ROCE] was -16.46% in FY2024 (+9.99 pp), -26.45% in FY2023 (+24.21 pp), -50.65% in FY2022 (+26.36 pp) and -77.02% in FY2021 (-17.53 pp).
  • Quarterly Return on Capital Employed [ROCE] has run from a low of -134.07% in Q1 2026 to a high of -3.64% in Q4 2025 over five years.
  • On a year-over-year basis, Return on Capital Employed [ROCE] increased in six of the last eight quarters, with an average year-over-year change of -21.73 percentage points.
  • The strongest year-over-year quarter for Return on Capital Employed [ROCE] in the past five years was Q3 2022, with a gain of 35.21 percentage points; the weakest was Q1 2026, with a drop of 120.26 percentage points.
  • According to Business Quant data, Return on Capital Employed [ROCE] for the three prior quarters was -134.07% (Q1 2026), -3.64% (Q4 2025) and -7.02% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 46.74%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 17.83%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 17.92%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 6.28%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 19.32%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 9.54%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 16.66%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -5.97%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 11.86%
10 Mirum Pharmaceuticals 5.37 Bn 3.79 Bn 145.90 Mn -111.92%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -111.92%
Mar 31, 2026 -134.07%
Dec 31, 2025 -3.64%
Sep 30, 2025 -7.02%
Jun 30, 2025 -10.13%
Mar 31, 2025 -13.80%
Dec 31, 2024 -16.14%
Sep 30, 2024 -17.49%
Jun 30, 2024 -19.93%
Mar 31, 2024 -19.96%
Dec 31, 2023 -19.44%
Sep 30, 2023 -23.44%
Jun 30, 2023 -35.86%
Mar 31, 2023 -42.68%
Dec 31, 2022 -44.65%
Sep 30, 2022 -51.05%
Jun 30, 2022 -62.91%
Mar 31, 2022 -62.95%
Dec 31, 2021 -78.00%
Sep 30, 2021 -86.26%
API Access

Mirum Pharmaceuticals Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=MIRM&period=max&api_key=YOUR_API_KEY